ECSP045378A - Derivados novedosos de diazabiciclononeno - Google Patents

Derivados novedosos de diazabiciclononeno

Info

Publication number
ECSP045378A
ECSP045378A EC2004005378A ECSP045378A ECSP045378A EC SP045378 A ECSP045378 A EC SP045378A EC 2004005378 A EC2004005378 A EC 2004005378A EC SP045378 A ECSP045378 A EC SP045378A EC SP045378 A ECSP045378 A EC SP045378A
Authority
EC
Ecuador
Prior art keywords
derivatives
diazabiciclononene
new
compounds
preparation
Prior art date
Application number
EC2004005378A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=29286070&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ECSP045378(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of ECSP045378A publication Critical patent/ECSP045378A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4995—Pyrazines or piperazines forming part of bridged ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Ophthalmology & Optometry (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Vascular Medicine (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La invención se refiere a derivados novedosos del 3,9-diaza biciclo[3.3.1]noneno y compuestos relacionados y su uso como ingredientes activos en la preparación de composiciones farmacéuticas. La invención también se refiere a aspectos relacionados que incluyen procesos para la preparación de los compuestos, composiciones farmacéuticas que contienen uno o más de esos compuestos y en especial su uso como inhibidores de la renina.
EC2004005378A 2002-04-29 2004-10-22 Derivados novedosos de diazabiciclononeno ECSP045378A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP0204705 2002-04-29

Publications (1)

Publication Number Publication Date
ECSP045378A true ECSP045378A (es) 2004-11-26

Family

ID=29286070

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2004005378A ECSP045378A (es) 2002-04-29 2004-10-22 Derivados novedosos de diazabiciclononeno

Country Status (26)

Country Link
US (2) US7427613B2 (es)
EP (1) EP1501830B1 (es)
JP (1) JP4041123B2 (es)
KR (1) KR100783863B1 (es)
CN (1) CN1649870A (es)
AT (1) ATE527261T1 (es)
AU (1) AU2003233963B2 (es)
BR (1) BR0309498A (es)
CA (1) CA2483241C (es)
CL (1) CL2003002042A1 (es)
CO (1) CO5631443A2 (es)
EC (1) ECSP045378A (es)
ES (1) ES2372931T3 (es)
HR (1) HRP20041132A2 (es)
IL (1) IL164767A0 (es)
IS (1) IS7545A (es)
MA (1) MA27305A1 (es)
MX (1) MXPA04010608A (es)
NO (1) NO20045042L (es)
NZ (1) NZ536750A (es)
PL (1) PL372141A1 (es)
RU (1) RU2343153C2 (es)
TW (1) TW200514786A (es)
UA (1) UA80821C2 (es)
WO (1) WO2003093267A1 (es)
ZA (1) ZA200408283B (es)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2521951A1 (en) * 2003-04-28 2004-11-11 Actelion Pharmaceuticals Ltd Diazabicyclononene and tetrahydropyridine derivatives as renin inhibitors
JP2006524654A (ja) * 2003-04-30 2006-11-02 アクテリオン　ファマシューティカルズ　リミテッド 新規アザビシクロノネン誘導体
JP2006524655A (ja) * 2003-04-30 2006-11-02 アクテリオン　ファマシューティカルズ　リミテッド ３−位にヘテロ原子を有する新規９−アザビシクロノネン誘導体
WO2004096799A1 (en) * 2003-04-30 2004-11-11 Actelion Pharmaceuticals Ltd Tropane derivatives and their use as ace inhibitors
MXPA05011711A (es) * 2003-05-02 2006-01-23 Actelion Pharmaceuticals Ltd Derivados de diazabiciclononeno.
WO2004105762A1 (en) * 2003-05-30 2004-12-09 Actelion Pharmaceuticals Ltd Medical use of diazabicyclononene derivatives as inhibitors of parasite aspartic proteases
AU2004283814A1 (en) * 2003-10-09 2005-05-06 Actelion Pharmaceuticals Ltd. Tetrahydropyridine derivatives
CA2540782A1 (en) * 2003-10-13 2005-05-06 Olivier Bezencon Diazabicyclononene derivatives and their use as renin inhibitors
AU2004283854A1 (en) * 2003-10-23 2005-05-06 Actelion Pharmaceuticals Ltd Diazabicyclononene and tetrahydropyridine derivatives as renin inhibitors
US20070135406A1 (en) * 2003-12-05 2007-06-14 Olivier Bezencon Diazabicyclononene and tetrahydropyridine derivatives with a new side-chain
WO2005054243A1 (en) * 2003-12-05 2005-06-16 Actelion Pharmaceuticals Ltd Diazabicyclononene derivatives and their use as renin inhibitors
CA2577084A1 (en) * 2004-08-25 2006-03-02 Olivier Bezencon Bicyclononene derivatives as renin inhibitors
WO2006021399A2 (en) * 2004-08-25 2006-03-02 Actelion Pharmaceuticals Ltd Azabicyclononene derivatives as renin inhibitors
WO2006021403A1 (en) * 2004-08-25 2006-03-02 Actelion Pharmaceuticals Ltd Bicyclononene derivatives
WO2006021401A2 (en) * 2004-08-25 2006-03-02 Actelion Pharmaceuticals Ltd Bicylononene derivatives
TW200634014A (en) * 2004-12-08 2006-10-01 Actelion Pharmaceuticals Ltd Novel diazabicyclononene derivative
WO2006063610A1 (en) * 2004-12-17 2006-06-22 Actelion Pharmaceuticals Ltd Heteroaryl substituted diazabicyclononene derivatives
GB0428526D0 (en) 2004-12-30 2005-02-09 Novartis Ag Organic compounds
JP4111533B1 (ja) * 2005-01-28 2008-07-02 アクテリオン ファーマシューティカルズ リミテッド 高血圧症の治療のためのレニンの阻害剤としての７−｛４−［２−（２，６−ジクロロ−４−メチルフェノキシ）エトキシ］フェニル｝−３，９−ジアザビシクロ［３．３．３１］ノン−６−エン−６−カルボン酸シクロプロピル−（２，３−ジメチルベンジル）アミド
EP1893578A2 (en) 2005-05-27 2008-03-05 Actelion Pharmaceuticals Ltd. Novel piperidine carboxylic acid amide derivatives
GB0514203D0 (en) 2005-07-11 2005-08-17 Novartis Ag Organic compounds
EP2420491B1 (en) 2005-12-30 2013-07-03 Novartis AG 3 , 5-substitued piperidine compounds as renin inhibitors
RU2425032C2 (ru) * 2006-02-02 2011-07-27 Актелион Фармасьютикалз Лтд Вторичные амины в качестве ингибиторов ренина
AR059886A1 (es) * 2006-03-08 2008-05-07 Actelion Pharmaceuticals Ltd Derivados de amidas como inhibidores de renina
EP2162436A4 (en) 2007-05-24 2010-08-04 Merck Frosst Canada Ltd NEW CASE OF RENININHIBITORS
SG182223A1 (en) 2007-06-25 2012-07-30 Novartis Ag N5-(2-ethoxyethyl)-n3-(2-pyridinyl)-3,5-piperidinedicarboxamide derivatives for use as renin inhibitors
JP2010536800A (ja) 2007-08-20 2010-12-02 メルク フロスト カナダ リミテツド レニン阻害剤
NZ589019A (en) 2008-05-05 2012-10-26 Merck Frosst Canada Ltd 3, 4 - substituted piperidine derivatives as renin inhibitors
CN109721613B (zh) * 2017-10-27 2021-07-30 四川科伦博泰生物医药股份有限公司 含季铵离子的大环酰胺化合物及其药物组合物和用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3509161A (en) * 1967-07-10 1970-04-28 Boehringer & Soehne Gmbh 3-phenyl-granatene-(2)-derivatives
GB9020927D0 (en) 1990-09-26 1990-11-07 Beecham Group Plc Pharmaceuticals
US5268361A (en) * 1991-06-07 1993-12-07 Sri International Hydroxyazido derivatives and related compounds as renin inhibitors
US5374719A (en) * 1993-06-04 1994-12-20 Eli Lilly And Company Process for converting loracarbef dihydrate to loracarbef monohydrate
KR100384979B1 (ko) 1995-09-07 2003-10-17 에프. 호프만-라 로슈 아게 심부전증및신부전증치료용의신규한4-(옥시알콕시페닐)-3-옥시-피페리딘
EP0966464B1 (en) 1997-03-03 2003-05-28 Basilea Pharmaceutica AG Substituted 2,4-diaminopyrimidines
US20060223795A1 (en) * 2003-05-02 2006-10-05 Oliver Bezencon Novel diazabicyclononene derivatives
WO2005054243A1 (en) * 2003-12-05 2005-06-16 Actelion Pharmaceuticals Ltd Diazabicyclononene derivatives and their use as renin inhibitors

Also Published As

Publication number Publication date
ATE527261T1 (de) 2011-10-15
US7427613B2 (en) 2008-09-23
ES2372931T3 (es) 2012-01-27
KR100783863B1 (ko) 2007-12-10
MXPA04010608A (es) 2004-12-13
KR20040101546A (ko) 2004-12-02
NZ536750A (en) 2007-02-23
JP2005527602A (ja) 2005-09-15
CL2003002042A1 (es) 2005-02-04
CN1649870A (zh) 2005-08-03
RU2343153C2 (ru) 2009-01-10
TW200514786A (en) 2005-05-01
AU2003233963A1 (en) 2003-11-17
EP1501830B1 (en) 2011-10-05
AU2003233963B2 (en) 2008-09-11
JP4041123B2 (ja) 2008-01-30
IL164767A0 (en) 2005-12-18
CO5631443A2 (es) 2006-04-28
US20050176700A1 (en) 2005-08-11
HRP20041132A2 (en) 2006-07-31
ZA200408283B (en) 2006-05-31
NO20045042L (no) 2004-11-19
WO2003093267A1 (en) 2003-11-13
RU2004134320A (ru) 2005-08-27
US20080312242A1 (en) 2008-12-18
BR0309498A (pt) 2005-02-15
IS7545A (is) 2004-11-22
MA27305A1 (fr) 2005-05-02
CA2483241A1 (en) 2003-11-13
PL372141A1 (en) 2005-07-11
EP1501830A1 (en) 2005-02-02
UA80821C2 (en) 2007-11-12
CA2483241C (en) 2011-05-31

Similar Documents

Publication Publication Date Title
ECSP045378A (es) Derivados novedosos de diazabiciclononeno
TW200514772A (en) Novel tetrahydropyridine derivatives
MXPA05010137A (es) Derivados de tetrahidroisoquinolil acetamida para usarse como antagonistas del receptor de orexina.
ATE286500T1 (de) 1,2,3,4-tetrahydroisochinolin-derivate
NO20051102L (no) Sulfonylamino-eddiksyre-derivater
AU2003228770A8 (en) Substituted pyrazolopyrimidines
ATE300541T1 (de) Pyrazolopyridinderivate
MXPA05011711A (es) Derivados de diazabiciclononeno.
MXPA05011496A (es) Derivados de azabiciclononeno.
MXPA05011498A (es) Derivados de 9-azabiciclo[3.3.1]non-6-eno con un heteroatomo en la posicion 3 como inhibidores de renina.
WO2005030209A8 (en) Pyridine derivatives and use thereof as urotensin ii antagonists
MXPA05011497A (es) Derivados de tropano y su uso como inhibidores de la enzima de conversion de angiotensina (ace).
MXPA03000606A (es) Derivados de benzofurano y su uso como agentes antibacterianos.
MXPA04001773A (es) Derivados de 6,7-dihidroxitetrahidroisquinolinas 3-sustituidas parta uso como agentes antibacterianos.
TW200637861A (en) Novel diazabicyclononene derivative
ATE274515T1 (de) Pyrazolopyridinderivate
ATE462703T1 (de) Bicyclononen-derivate als renin-inhibitoren
TW200628468A (en) Bicyclononene derivatives
TW200634014A (en) Novel diazabicyclononene derivative
TW200621774A (en) Bicyclononene derivatives
SG146685A1 (en) Dihydroporphine derivatives, processes for their preparation, and pharmaceutical compositions containing them
WO2006021399A3 (en) Azabicyclononene derivatives as renin inhibitors
WO2006059304A3 (en) Novel lactame derivatives as renin inhibitors
MXPA05014081A (es) Derivados de benzofurano y su uso en el tratamiento de infecciones microbianas.
WO2004105738A3 (en) Use of tetrahydropyridine derivatives